Chen-Hua Lin1, Hao-Min Cheng1,2,3,4,5, Shao-Yuan Chuang6, Chen-Huan Chen1,2,4,5. 1. Institute of Public Health, National Yang-Ming University, Taipei, ROC. 2. Faculty of Medicine, National Yang-Ming University, Taipei, ROC. 3. Center for Evidence-Based Medicine, Taipei Veterans General Hospital, Taipei, ROC. 4. Department of Medical Education, Taipei Veterans General Hospital, Taipei, ROC. 5. Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, ROC. 6. National Health Research Institutes, Miaoli, Taiwan, ROC.
Abstract
BACKGROUND: Vascular aging may cause cerebral microvascular damage and cognitive dysfunction. There is incremental evidence that consistently implicates arterial stiffness being involved in the manifestation of cognitive impairment in the elderly. However, few investigations have examined the relationship between arterial stiffness and cognitive impairment in midlife. SUMMARY: Past studies inconsistently showed improved cognitive outcomes after antihypertensive therapy in elderly populations. Nevertheless, recent findings revealed that blood-pressure-lowering treatment in young adults might eliminate or halt the progression of the detrimental effects related to arterial stiffness, indicating that younger adults may have more favorable outcomes in cognition than their older counterparts if early intervention is conducted at the subclinical stage. Stiffening of the aorta may lead to an excessive flow pulsatility in the brain that may cause microvascular structural brain damage and worse cognitive performance. Recent investigations have suggested that arterial stiffness is likely to trigger initial silent brain damage, possibly preceding midlife, while the manifestation of cognitive decline and deterioration can be foreseen in the subsequent life span. KEY MESSAGE: Despite the recent novel findings, definite conclusions on causality between vascular aging and cognitive dysfunction cannot be drawn at present. Further well-powered longitudinal studies with superior neuroimaging indicator, vascular mechanical biomarkers, and sensitive cognitive assessment tools that examine a broad range of age populations may help extend our understanding of the association between vascular aging and cognitive dysfunction throughout the life span.
BACKGROUND: Vascular aging may cause cerebral microvascular damage and cognitive dysfunction. There is incremental evidence that consistently implicates arterial stiffness being involved in the manifestation of cognitive impairment in the elderly. However, few investigations have examined the relationship between arterial stiffness and cognitive impairment in midlife. SUMMARY: Past studies inconsistently showed improved cognitive outcomes after antihypertensive therapy in elderly populations. Nevertheless, recent findings revealed that blood-pressure-lowering treatment in young adults might eliminate or halt the progression of the detrimental effects related to arterial stiffness, indicating that younger adults may have more favorable outcomes in cognition than their older counterparts if early intervention is conducted at the subclinical stage. Stiffening of the aorta may lead to an excessive flow pulsatility in the brain that may cause microvascular structural brain damage and worse cognitive performance. Recent investigations have suggested that arterial stiffness is likely to trigger initial silent brain damage, possibly preceding midlife, while the manifestation of cognitive decline and deterioration can be foreseen in the subsequent life span. KEY MESSAGE: Despite the recent novel findings, definite conclusions on causality between vascular aging and cognitive dysfunction cannot be drawn at present. Further well-powered longitudinal studies with superior neuroimaging indicator, vascular mechanical biomarkers, and sensitive cognitive assessment tools that examine a broad range of age populations may help extend our understanding of the association between vascular aging and cognitive dysfunction throughout the life span.
Authors: Mariëlle M F Poels; Marieke van Oijen; Francesco U S Mattace-Raso; Albert Hofman; Peter J Koudstaal; Jacqueline C M Witteman; Monique M B Breteler Journal: Stroke Date: 2007-02-01 Impact factor: 7.914
Authors: Matthew P Pase; Jayandra J Himali; Gary F Mitchell; Alexa Beiser; Pauline Maillard; Connie Tsao; Martin G Larson; Charles DeCarli; Ramachandran S Vasan; Sudha Seshadri Journal: Hypertension Date: 2016-01-11 Impact factor: 10.190
Authors: Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman Journal: JAMA Neurol Date: 2017-10-01 Impact factor: 18.302
Authors: Pauline Maillard; Gary F Mitchell; Jayandra J Himali; Alexa Beiser; Connie W Tsao; Matthew P Pase; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri; Charles DeCarli Journal: Stroke Date: 2016-03-10 Impact factor: 7.914
Authors: Léon H G Henskens; Abraham A Kroon; Robert J van Oostenbrugge; Ed H B M Gronenschild; Monique M J J Fuss-Lejeune; Paul A M Hofman; Jan Lodder; Peter W de Leeuw Journal: Hypertension Date: 2008-10-13 Impact factor: 10.190
Authors: Connie W Tsao; Sudha Seshadri; Alexa S Beiser; Andrew J Westwood; Charles Decarli; Rhoda Au; Jayandra J Himali; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Martin G Larson; Emelia J Benjamin; Philip A Wolf; Ramachandran S Vasan; Gary F Mitchell Journal: Neurology Date: 2013-08-09 Impact factor: 9.910
Authors: Joel Singer; Julian N Trollor; John Crawford; Michael F O'Rourke; Bernhard T Baune; Henry Brodaty; Katherine Samaras; Nicole A Kochan; Lesley Campbell; Perminder S Sachdev; Evelyn Smith Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240